Pulmozyme is an innovative drug used to improve lung function in patients with cystic fibrosis. This article will analyze the price, dosage and precautions of the drug to help readers fully understand the key information of this drug.

Price of Dornase Alfa(Pulmozyme)

Dornase Alfa(Pulmozyme) is an imported drug, and its price is one of the key concerns of patients. Understanding the pricing and specifications of the drug will help patients to reasonably plan the cost of treatment.

Drug specifications and pricing

The specifications of Dornase Alfa(Pulmozyme) are 2.5mg/2.5mL*30 bottles. This price reflects the R&D and production costs of innovative drugs, and is also closely related to market demand.

Market and medical insurance status

Currently, the drug has not been launched in China and has not been included in the Chinese medical insurance catalog. There are currently no generic drugs available on the market, and patients need to purchase original drugs through specific channels.

The price of Dornase Alfa(Pulmozyme) is high, but its efficacy for patients with cystic fibrosis is obvious. Patients need to weigh the economic cost and treatment effect when making a choice, and pay attention to the possible future medical insurance inclusion dynamics.

Usage and dosage of Pulmozyme

The correct usage and dosage are the key to confirming the efficacy of the drug. The usage of Pulmozyme is relatively special and must be strictly followed in accordance with the recommended dose and operating specifications.

Recommended dose and administration method

The recommended dose for most cystic fibrosis patients is 2.5mg (single-dose ampoule), once a day. The drug needs to be inhaled through a jet nebulizer or a vibrating mesh nebulizer to ensure that the drug can effectively reach the lungs.

Selection and use of Pulmozyme

When using Pulmozyme, a suitable nebulizer system, such as the eRapid nebulizer, is required. It should be noted that patients of different ages have different adaptability to nebulizers, and pediatric patients should avoid using equipment that is only suitable for adults.

The usage and dosage of Pulmozyme should be combined with the patient's specific situation and equipment conditions. Strictly following the operating specifications can maximize the therapeutic effect of the drug and reduce unnecessary waste.

Precautions for the use of Pulmozyme

Medication safety is the top priority during the treatment process. Understanding the adverse reactions of Pulmozyme and medication information for special populations will help avoid potential risks.

Common adverse reactions

Clinical trials have shown that some patients may experience adverse reactions such as voice changes, pharyngitis, and rashes. If symptoms persist or worsen, seek medical attention in time to adjust the treatment plan.

Medication for special populations

Pregnant women, breastfeeding women, and children should use it under the guidance of a doctor. Although existing data do not show harm to the fetus, the safety of medication for breastfeeding women is still unclear.

Precautions for the use of Pulmozyme involve multiple aspects, and patients need to maintain close communication with their doctors. Scientific medication can effectively improve the treatment effect while reducing potential risks.